natgillin/translations-raw huggingface dataset:
recommended.
gospinu travu.
recommended.
imatiniba.
recommended.
inhibitorima protonske pumpe.
recommended.
liječenja flukonazolom.
recommended.
Ne preporučuje se istodobna
recommended.
ne preporučuje.
recommended.
potrebno primjenjivati atazanavir
recommended.
praćenje.
recommended.
preporučena.
recommended.
Preporučuje se neka druga
recommended.
preporučuje.
recommended.
primjena.
recommended.
se klinički nadzor.
recommended.
se ne preporučuje.
Reconcile 16 mg tablet
Tableta Reconcile 16 mg
Reconcile 16 mg tablets: 4205
Reconcile tablete 16 mg: 4205
Reconcile 16mg tablet
Reconcile tableta 16 mg
Reconcile 32 mg tablet
Tableta Reconcile 32 mg
Reconcile 32 mg tablets: 4207
Reconcile tablete 32 mg: 4207
Reconcile 32mg tablet
Reconcile tableta 32 mg
Reconcile 64 mg tablet
Tableta Reconcile 64 mg
Reconcile 64 mg tablets: 4209
Reconcile tablete 64 mg: 4209
Reconcile 64mg tablet
Reconcile tableta 64 mg
Reconcile 8 mg chewable tablets for dogs Reconcile 16mg chewable tablets for dogs Reconcile 32 mg chewable tablets for dogs Reconcile 64 mg chewable tablets for dogs
Tablete za žvakanje za pse Reconcile 8 mg Tablete za žvakanje za pse Reconcile 16 mg Tablete za žvakanje za pse Reconcile 32 mg Tablete za žvakanje za pse Reconcile 64 mg
Reconcile 8 mg tablet
Tableta Reconcile 8 mg
Reconcile 8 mg: fluoxetine 8.0 mg (equivalent to 9.04 mg fluoxetine hydrochloride) Reconcile 16mg: fluoxetine 16.0mg (equivalent to 18.08mg fluoxetine hydrochloride) Reconcile 32 mg: fluoxetine 32.0 mg (equivalent to 36.16 mg fluoxetine hydrochloride) Reconcile 64 mg: fluoxetine 64.0 mg (equivalent to 72.34 mg fluoxetine hydrochloride)
Reconcile od 8 mg: fluoksetin 8,0 mg (odgovara 9,04 mg fluoksetin-hidroklorida) Reconcile 16 mg: fluoksetin 16,0 mg (odgovara 18,08 mg fluoksetin-hidroklorida) Reconcile 32 mg: fluoksetin 32,0 mg (odgovara 36,16 mg fluoksetin-hidroklorida) Reconcile 64 mg: fluoksetin 64,0 mg (odgovara 72,34 mg fluoksetin-hidroklorida)
Reconcile 8 mg: Fluoxetine 8.0 mg (equivalent to 9.04 mg fluoxetine hydrochloride) Reconcile 16mg: Fluoxetine 16.0mg (equivalent to 18.08mg fluoxetine hydrochloride) Reconcile 32 mg: Fluoxetine 32.0 mg (equivalent to 36.16 mg fluoxetine hydrochloride) Reconcile 64 mg:Fluoxetine 64.0 mg (equivalent to 72.34 mg fluoxetine hydrochloride)
Reconcile 8 mg: Fluoksetin 8 mg (odgovara 9,04 mg fluoksetin-hidroklorida) Reconcile 16 mg: Fluoksetin 16 mg (odgovara 18,08 mg fluoksetin-hidroklorida) Reconcile 32 mg: Fluoksetin 32 mg (odgovara 36,16 mg fluoksetin-hidroklorida) Reconcile 64 mg: Fluoksetin 64 mg (odgovara 72,34 mg fluoksetin-hidroklorida)
Reconcile 8mg tablet
Reconcile tableta 8 mg
Reconcile are flavoured and most dogs will consume the tablet when offered by the owner.
Reconcile tablete imaju okus i većina će pasa uzeti tabletu koju im ponudi vlasnik.
Reconcile fluoxetine
EMEA/V/C/000133
Reconcile has been authorised since 8 July 2008 as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination) and only in combination with behavioural modification techniques.
Reconcile je odobren još 8. srpnja 2008. kao pomoć u liječenju poremećaja pasa koji nastaju zbog poremećaja povezanih s odvajanjem i manifestiraju se destruktivnošću i neprikladnim ponašanjem (glasanje ili neprihvatljivo obavljanje nužde) i to samo u kombinaciji s tehnikama za promjenu ponašanja.
Reconcile is a speckled tan to brown round chewable tablet containing:
Reconcile je prošarana tamnožuta do smeđa okrugla tableta za žvakanje koja sadrži:
Reconcile should be administered orally at a once daily dose of 1 to 2 mg/kg bodyweight according to the dosage table below:
Reconcile treba dati oralno u jednoj dnevnoj dozi od 1 do 2 mg po kg tjelesne težine u skladu s donjom tablicom za doziranje:
Reconcile should not be given concomitantly with veterinary medicinal products that lower the seizure threshold (e.g. phenothiazines such as acepromazine or chlorpromazine).
Reconcile ne bi trebalo davati zajedno s medicinskim proizvodima koji smanjuju prag za napadaje (npr. fenotijazini poput acepromazina i klorpromazina).
Reconcile tablets are used as an aid in the treatment of separation-related disorders in dogs, such as destruction and vocalisation and inappropriate defaecation and/or urination.
Reconcile tablete koriste se kao pomoć u liječenju poremećaja u pasa povezanih s odvajanjem, poput destruktivnosti, glasanja i neprikladnog obavljanja nužde.
Reconcile tablets may be given with or without food and are flavoured so that most dogs will consume the tablet when offered by the owner.
Tablete Reconcile mogu se davati sa hranom ili bez i imaju okus, pa će ih većina pasa uzeti kad im ih vlasnik ponudi.
Reconcile tablets may be given with or without food.
Reconcile tablete mogu se davati s hranom ili bez nje.
Reconcile tablets should be administered orally with or without food.
Tablete Reconcile treba davati oralno s hranom ili bez nje.
Reconcile tablets should not be used in dogs with epilepsy or a history of seizures
Tablete Reconcile ne bi trebalo koristiti kod pasa s epilepsijom ili epizodama napadaja
Reconsituted/diluted solution: Use immediately.
Rekonstituirana/razrijeđena otopina: Upotrijebiti odmah.
Reconst. ⏐ ⏐ ⏐ ⏐
Dat. pripreme    
Reconstitute 1,000 mg vials with 40 ml of sodium chloride 9 mg/ml (0.9%) solution for injection, without preservative.
Bočice od 1000 mg rekonstituirajte s 40 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa.
Reconstitute 100 mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Bočice od 100 mg rekonstituirajte s 4,2 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute 100 mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9%) solution for injection, without preservative.
Bočice od 100 mg rekonstituirajte s 4,2 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa.
Reconstitute 100-mg vials with 4.2 mL of sodium chloride 9 mg/mL (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/mL pemetrexed.
Bočice od 100 mg rekonstituirajte s 4,2 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute 1000-mg vials with 40 ml of sodium chloride 9 mg/ml (0.9%) solution for injection (without preservative), resulting in a solution containing 25 mg/ml pemetrexed.
Bočice od 500 mg rekonstituirajte s 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), (bez konzervansa), čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute 500 mg vials with 20 mL of sodium chloride 9 mg/mL (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/mL pemetrexed.
Bočice od 500 mg rekonstituirajte s 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute 500 mg vials with 20 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Bočice od 500 mg rekonstituirajte sa 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute 500 mg vials with 20 ml of sodium chloride 9 mg/ml (0.9%) solution for injection, without preservative.
Bočice od 500 mg rekonstituirajte s 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa.
Reconstitute 500-mg vials with 20 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Bočice od 500 mg rekostituirajte s 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute all ReFacto AF pre-filled syringes according to instructions shown above in the reconstitution directions (see Reconstitution and Administration).
Pripremite sve ReFacto AF napunjene štrcaljke prema uputama prikazanima gore u uputama za pripremu (pogledajte Priprema i primjena).
Reconstitute and dilute before use
Rekonstituirati i razrijediti prije primjene.
Reconstitute and dilute before use – see leaflet.
Prije primjene potrebno je pripremiti i razrijediti – vidjeti Uputu o lijeku.
Reconstitute and dilute before use – see leaflet.
Prije primjene rekonstituirati i razrijediti - vidjeti Uputu o lijeku.
Reconstitute and dilute before use.
Prije primjene lijek se mora rekonstituirati i razrijediti.
Reconstitute and dilute before use.
Pripremiti i razrijediti prije primjene.
Reconstitute Dynastat 40 mg with 2 ml sodium chloride 9 mg/ml (0.9%) solution.
Rekonstituirajte Dynastat 40 mg s 2 ml otopine natrijevog klorida 9 mg/ml (0,9%).
Reconstitute each 50 mg vial of Myozyme with 10.3 ml water for injections using a syringe with a needle diameter not larger than 20 gauge.
Rekonstituirajte svaku bočicu od 50 mg lijeka Myozyme s 10,3 ml vode za injekcije.
Reconstitute each 500 mg vial with 20 ml of 9 mg/ml (0.9%) sodium chloride solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Svaku bočicu od 500 mg rekonstituirajte sa 20 ml otopine natrijeva klorida za injekciju od 9 mg/ml (0,9%), bez konzervansa, čime se dobiva otopina koja sadrži 25 mg/ml pemetrekseda.
Reconstitute immediately after removal from the refrigerator (or other cold storage).
Rekonstituirati odmah nakon vađenja iz hladnjaka (ili drugog hladnog spremišta).
Reconstitute lyophilised CEPROTIN powder for solution for injection, with the supplied solvent (Sterilised Water for Injections) using the sterile transfer needle.
Pripremite liofilizirani prašak lijeka CEPROTIN za otopinu za injekciju pomoću priloženog otapala (sterilizirana voda za injekcije) koristeći sterilnu iglu za prijenos.
Reconstitute one dose of lyophilisate with one dose of solvent, shake gently and administer immediately.
Rekonstituirati jednu dozu liofilizata s jednom dozom otapala, nježno promućkati i odmah aplicirati.
Reconstitute one vial of the white lyophilisate using 0.5 ml of solvent.
Rekonstituirati jednu bočicu bijelog liofilizata s 0,5 ml otapala.
Reconstitute the content of Ilaris vial at room temperature (typically 15°C to 25°C) by slowly injecting 1.0 ml of water for injections withdrawn from the solvent vial.
Rekonstituirajte sadržaj bočice Ilarisa na sobnoj temperaturi (obično 15°C do 25°C) tako da polako ubrizgate 1,0 ml vode za injekcije koju ste izvukli iz bočice s otapalom.
Reconstitute the contents with water for injections and dilute before use.
Prije primjene pripremite sadržaj s vodom za injekcije i razrijedite.
Reconstitute the desired amount of product, repeating steps 2 - 9, using a new syringe and connect it to the venipuncture set.
Pripremite željenu količinu lijeka ponavljajući korake od 2 do 9, koristeći novu štrcaljku te je priključite na set za venepunkciju.
Reconstitute the lyophilisate by adding 5 ml (50-dose presentation) or 10 ml (200-dose presentation) of tap water to the vial.
Rekonstituirajte liofilizat dodavanjem 5 ml (50 doza) ili 10 ml (200 doza) tekuće vode u bočicu.
Reconstitute the lyophilisate immediately and entirely after opening of the cup.
Rekonstituirati liofilizat odmah i upotrijebiti cijelokupno nakon otvaranja.
Reconstitute the lyophilisate using water of good quality (e.g. free from chlorine and/or disinfectants).
Rekonstituirajte liofilizat koristeći vodu dobre kvalitete (npr. bez klora i/ili dezinficijensa).
Reconstitute the product as described in section 6.6. The reconstituted preparation should be injected/infused slowly intravenously at a rate comfortable for the patient.
Rekonstituirajte lijek kako je to opisano u dijelu 6.6. Rekonstituirani lijek treba injicirati/infundirati polako intravenski pri brzini koja odgovara bolesniku.
Reconstitute the product as described in section 6.6. The reconstituted preparation should be injected/infused slowly intravenously at a rate comfortable for the patient.
Rekonstituirajte lijek kako je to opisano u dijelu 6.6. Rekonstituirani lijek treba injicirati/infundirati polakointravenski pri brzini koja odgovara bolesniku.
Reconstitute vedolizumab with 4.8 ml of sterile water for injection, using a syringe with a 21-25 gauge needle.
Rekonstituirajte vedolizumab sa 4,8 ml sterilne vode za injekcije uporabom štrcaljke s iglom veličine 21G-25G.
Reconstitute with 94 mL of purified water.
Rekonstituirati s 94 ml pročišćene vode.
Reconstitute ZYPREXA Powder for Solution for Injection only with water for injections.
Rekonstituirajte ZYPREXA prašak za otopinu za injekciju samo s vodom za injekcije.
Reconstitute ZYPREXA Powder for Solution for Injection using standard aseptic techniques for reconstitution of parenteral products.
Rekonstituirajte lijek ZYPREXA samo s vodom za injekcije primjenom standardnih aseptičkih tehnika za rekonstituciju parenteralnih lijekova.
reconstituted
rekonstituiranog
Reconstituted and diluted solutions
Pripremljene i razrijeđene otopine
Reconstituted concentrate in vial:
Rekonstituirani koncentrat u bočici:
Reconstituted Kepivance contains 5 mg/ml of palifermin
Nakon pripreme za primjenu, Kepivance sadrži 5 mg/ml palifermina
Reconstituted medicinal product should be inspected visually for particulate matter and discoloration prior to administration.
Prije primjene potrebno je vizualno pregledati rekonstituiranu otopinu na prisutnost čestica i promjenu boje.
Reconstituted medicinal product should be inspected visually for particulate matter and discoloration prior to administration.
Prije primjene vizualno pregledajte rekonstituirani lijek i provjerite da ne sadrži čestice te da nije došlo do promjene boje.
Reconstituted medicinal products should be inspected visually for particulate matter and discoloration prior to administration.
Pripremljene lijekove potrebno je vizualno pregledati prije primjene kako biste provjerili sadrži li bilo kakve strane čestice ili je došlo do promjene boje.
Reconstituted NovoThirteen is a clear, colourless solution.
NovoThirteen pripremljen za primjenu je bistra i bezbojna otopina.
Reconstituted pixantrone solution is stable for up to 24 hours at room temperature (15C to 25C) in standard infusion bags.
Pripremljena otopina piksantrona stabilna je do 24 sata na sobnoj temperaturi (15 C do 25 C) u standardnim vrećicama za infuziju.
Reconstituted products should be inspected visually for particulate matter and discoloration prior to administration.
Pripremljene lijekove prije primjene treba vizualno provjeriti za prisutnost čestica ili promjenu boje.
Reconstituted Simulect can be administered as an intravenous bolus injection or as an intravenous infusion over 20–30 minutes.
Rekonstituirani Simulect se može primjenjivati kao intravenska bolus injekcija ili kao intravenska infuzija kroz 20-30 minuta.
Reconstituted solution
Pripremljena otopina
Reconstituted solution (BLINCYTO solution):
Rekonstituirana otopina (BLINCYTO otopina):
Reconstituted solution and infusion solution: Store at 15 – 30°C.
Rekonstituirani koncentrat i infuzijska otopina: čuvati na temperaturi od 15-30C.
Reconstituted solution and the diluted solution: store between 15°C and 30°C.
Pripremljenu otopinu i razrijeđenu otopinu čuvati na temperaturi od 15 do 30ºC
Reconstituted solution, for patients of body weight (kg):
Rekonstituirana otopina, za bolesnike s tjelesnom težinom (kg):
Reconstituted solution: Chemical and physical in-use stability has been demonstrated for 24 hours at 2-8oC.
Rekonstituirana otopina: Kemijska i fizikalna stabilnost u uporabi dokazana je za 24 sata pri 2-8 oC.
Reconstituted solution: Chemical and physical in-use stability has been demonstrated for 24 hours at 2-8C.
Rekonstituirana otopina: Kemijska i fizikalna stabilnost u uporabi dokazana je za 24 sata pri 2-8 oC.
Reconstituted solution: chemical and physical in-use stability has been demonstrated for 28 days at 2- 8C.
Rekonstituirana otopina: kemijska i fizikalna stabilnost u upotrebi dokazana je tijekom 28 dana na 2- 8oC.
Reconstituted solution: Store in a refrigerator (2 – 8oC).
Rekonstituirana otopina: Čuvati u hladnjaku (2 – 8 oC).
Reconstituted solution: Store in a refrigerator (2-8C).
Rekonstituirana otopina: Čuvati u hladnjaku (2-8oC).
Reconstituted solution: Store in a refrigerator (2–8C).
Pripremljena otopina: Čuvati u hladnjaku (2 – 8 oC).
Reconstituted solutions of Cubicin range in colour from pale yellow to light brown.
Boja rekonstituirane otopine Cubicina kreće se u rasponu od blijedožute do svijetlosmeđe.
Reconstituted solutions should be diluted in sodium chloride 9 mg/mL (0.9 %) solution immediately after preparation.
Rekonstituirana otopina mora se razrijediti u otopini natrijevog klorida 9 mg/ml (0,9%) neposredno nakon pripreme.
Reconstituted suspension: do not store above 30°C.
Pripremljena suspenzija: ne čuvati na temperaturi iznad 30C.
Reconstituted vaccine: pink/red, or yellowish colour with slight opalescence
Rekonstituirano cjepivo: ružičasta/crvena do žućkasta boja s blagom opalescencijom.
Reconstituted vaccine: pinkish or yellowish colour with a slight opalescence.
Rekonstituirano cjepivo: bjelkasta do žućkasta boja s blagom opalescencijom.
Reconstituted vaccine: pinkish or yellowish colour with a slight opalescence.
Rekonstituirano cjepivo: bjelkaste do žućkaste boje s blagom opalescencijom.
Reconstituted vaccine: pinkish, or yellowish colour with slight opalescence.
Rekonstituirano cjepivo: ružičasta ili žućkasta boja s blagom opalescencijom.
Reconstituted vaccine: Whitish to yellowish colour with light opalescence.
Rekonstituirano cjepivo: bjelkaste do žućkaste boje s blagom opalescencijom.
Reconstituted VFEND needs to be diluted with a compatible infusion solution first before it is infused. (Please refer to the end of this leaflet for further information).
Pripremljeni VFEND mora se prije infuzije razrijediti s kompatibilnom infuzijskom otopinom. (Dodatne informacije navedene su na kraju ove Upute o lijeku).
Reconstituted Vidaza should be injected subcutaneously (insert the needle at a 45-90o angle) using a 25-gauge needle into the upper arm, thigh or abdomen.
Rekonstituiranu Vidazu treba ubrizgati supkutano (iglu uvesti pod kutom od 45-90°) koristeći se iglom od 25 G u nadlakticu, bedro ili abdomen.
Reconstituted Vidaza should be injected subcutaneously into the upper arm, thigh or abdomen.
Rekonstituiranu Vidazu treba injicirati supkutano u nadlakticu, bedro ili trbuh.
Reconstituted Xiapex can be kept at ambient room temperature (20ºC-25ºC) for up to one hour or refrigerated 2ºC-8˚C for up to 4 hours prior to administration.
Rekonstituirani Xiapex može se čuvati na sobnoj temperaturi (20ºC-25ºC) najviše jedan sat ili u hladnjaku na 2ºC-8˚C najviše 4 sata prije primjene.
Reconstituted Xiapex can be kept at ambient room temperature (20ºC-25ºC) for up to one hour or refrigerated at 2ºC-8˚C for up to 4 hours prior to administration.
Rekonstituirani Xiapex može se čuvati na sobnoj temperaturi (20ºC-25ºC) najduže jedan sat ili u hladnjaku na temperaturi od 2ºC do 8˚C najduže 4 sata prije primjene.
Reconstituted/diluted solutions:
Rekonstituirane/razrijeđene otopine:
Reconstituting and drawing up the solution for injection, step by step
Priprema i izvlačenje otopine za injekciju, korak po korak
Reconstituting Omnitrope
Rekonstitucija lijeka Omnitrope
Reconstituting the solution, step by step
Priprema otopine za injekciju, korak po korak
Reconstitution
Priprema
Reconstitution
Priprema lijeka
Reconstitution
Priprema lijeka za primjenu
Reconstitution
Priprema za primjenu
Reconstitution and administration by the patient
Rekonstitucija i primjena koju provodi bolesnik
Reconstitution and Administration card (this leaflet)
Uputu za rekonstituciju i primjenu (ovaj letak)
Reconstitution and administration of Respreeza
Priprema za primijenu i primjena Respreeze
Reconstitution and administration of ZYPREXA
Rekonstitucija i primjena lijeka ZYPREXA
Reconstitution and dilution needs to be carried out under aseptic conditions.
Rekonstitucija i razrjeđivanje moraju biti provedeni u aseptičkim uvjetima.
Reconstitution and dilution should be performed in accordance with good practices rules, particularly with respect to asepsis.
Pripremu i razrjeđivanje treba provesti sukladno pravilima dobre prakse, osobito s obzirom na asepsu.
Reconstitution and preparation for intravenous administration
Rekonstitucija i priprema za intravensku primjenu
Reconstitution and withdrawal must be carried out under aseptic conditions.
Rekonstitucia i izvlačenje mora se provesti u aseptičkim uvjetima.
Reconstitution and withdrawal must be carried out under aseptic conditions.
Rekonstitucija i izvlačenje moraju se provesti u aseptičnim uvjetima.
Reconstitution instructions intended for healthcare professionals are included at the end of the leaflet.
Upute za pripremu namijenjene zdravstvenim radnicima nalaze se na kraju ove Upute.
Reconstitution instructions intended for medical and healthcare professionals are included at the end of the leaflet
Upute za pripremu namijenjene zdravstvenim djelatnicima nalaze se na kraju ove Upute.
Reconstitution instructions intended for medical and healthcare professionals are included at the end of the package leaflet.
Upute za pripremu namijenjene zdravstvenim djelatnicima nalaze se na kraju ove upute o lijeku.
Reconstitution instructions:
Upute za rekonstituiranje:
Reconstitution needles (size 22G, length 1½" (0.7 x 40 mm))
Igle za pripremu otopine (veličine 22G, duljine 1½" (0,7 x 40 mm))
Reconstitution of product
rekonstituciju lijeka
Reconstitution of Savene powder to prepare a concentrate
Rekonstitucija praška Savene za pripremu koncentrata
Reconstitution of the product and administration
Rekonstitucija i primjena lijeka
RECONSTITUTION PACK INNER CARTON WITHOUT BLUE BOX
UNUTRANJE PAKIRANJE SETA ZA PRIPREMU, BEZ PLAVOG OKVIRA
RECONSTITUTION PACK OUTER CARTON WITH BLUE BOX
VANJSKO PAKIRANJE SETA ZA PRIPREMU, S PLAVIM OKVIROM
Reconstitution poster
Poster s uputstvima za rekonstituciju lijeka
Reconstitution process
Doziranje.
Reconstitution solvents
Otapala za rekonstituciju
Reconstitution time is not more than 5 minutes for the vial containing 250 mg and not more than 10 minutes for the vial containing 750 mg.
Vrijeme rekonstitucije nije dulje od 5 minuta za bočicu koja sadrži 250 mg i nije dulje od 10 minuta za bočicu koja sadrži 750 mg.
Reconstitution using the transfer device and solvent vial:
Rekonstitucija uz pomoć pomagala za prijenos i bočice s otapalom:
Reconstitution with the BAXJECT II device
Rekonstitucija pomoću uređaja BAXJECT II
Reconstitution with the BAXJECT III system
Rekonstitucija pomoću sustava BAXJECT III
Reconstitution yields either 4 ml or 10 ml of solution for injection respectively.
Rekonstitucijom se dobiva 4 mL ili 10 mL otopine za injekciju.
Reconstitution, dosing and administration booklet
Brošura s uputstvima za rekonstituciju, doziranje i primjenu lijeka
Reconstitution, product administration and handling of the administration set and needles must be done with caution.
Rekonstitucija, primjena lijeka i rukovanje kompletom za primjenu i iglama mora se provesti s oprezom.
Reconstitution, product administration and handling of the administration set and needles must be done with caution.
Rekonstitucija, primjena lijeka i rukovanje kompletom za primjenu i iglama moraju se provesti s oprezom.
Reconstitution/preparation for intravenous administration
Rekonstitucija/priprema za intravensku primjenu
Record date and location
Zabilježite datum i mjesto
Record the date and location of each injection.
Zabilježite datum i mjesto svake injekcije.
Record the date, time and site where you injected.
Zapišite datum, vrijeme i mjesto injekcije.
Record the following data in your treatment diary:
Bilježite sljedeće podatke u Vaš dnevnik liječenja:
Record the treatment day number (1), date (2) and time (3) of your injection.
Zabilježite broj dana liječenja (1), datum (2) i vrijeme (3) davanja injekcije.